Sugar coated tablets - 10 mg

Buskolamin contains as active substance hyoscine butylbromide. Hyoscine butylbromide is a quaternary ammonium salt. This drug, due to its anticholinergic action, possesses antispasmodic properties and it is used to relieve smooth muscle spasms.

Buskolamin 10 mg sugar-coated tablets are indicated in:

• gastrointestinal or genitourinary spasms;
• Irritable Bowel Syndrome.

Solution for injection - (40%) 4 g/10 ml

Film coated tablets - 10 mg

Aprolip contains the active substance atorvastatin calcium which belongs to a group of medicines known as statins, which are lipid (fat) regulating medicines.

Aprolip is used to lower lipids known as cholesterol and triglycerides in the blood when a low fat diet and life style changes on their own have failed. If you are at an increased risk of heart disease, Aprolip can also be used to reduce such risk even if your cholesterol levels are normal. You should maintain a standard cholesterol lowering diet during treatment.

Cream - 0.1% - 15 g

Ovules - 200 mg

Tablets - 4mg

Tablets - 100 mg

Doxyderma is a broad-spectrum antibiotic of the tetracycline group.

Doxyderma is indicated for infections caused by pathogens sensitive to doxycycline, especially by:

• Infections of therespiratory airways andear-nose-throatarea
• acute exacerbationsof chronicbronchitis
• sinusitis
• inflammation of the middle ear (Otitis media)
• certain forms of pulmonary inflammation (pneumonia)caused by mycoplasma, rickettsia or chlamydia
• Genitourinary tract infections urethritis caused by Chlamydia and Ureaplasma urealyticum
• acute prostatitis
• uncomplicated gonorrhea (especially with concurrent chlamydial infection)
• infections of the female genital organs
• syphilis, when there is penicillin allergy
• urinary tract infection (only in case of proven sensitivity of the pathogen)
• Infections of the gastrointestinal tract
• Cholera
• infections caused by Yersinia or Campylobacter
• Shigella infection in proved sensitivity
• Outpatient treatment of biliary tract infections
• Skin diseases, also infected severe forms of acne vulgaris and rosacea
• Conjunctivitis caused by chlamydia and trachoma
• Diseases caused by Borrelia such as erythema chronicum migrans and Lyme disease (mainly caused by infections from bites)
• Rare infections such as brucellosis, ornithosis, bartonellosis, listeriosis, rickettsiosis, melioidosis, plague, inguinal granuloma
• Other diseases: malabsorption syndrome (diseases associated with dyspepsia) for example tropical Sprue and Whipple's disease.

Gel - 1%

Durilac contains the active substance diclofenac sodium, which is a non-steroidal anti-inflammatory drug (NSAID). Its action is based in the inhibition of cyclooxygenases, which participate in the biosynthesis of prostaglandins. Prostaglandins have an important role in the process of pain, inflammation and chills. Non - steroidal anti-inflammatory drugs inhibit cyclooxygenases-1 and-2 (COX-1 and-2). Inhibition of COX-1 is associated with gastrointestinal side effects, while the inhibition of COX-2 is associated with anti-inflammatory action.

Diclofenac is rapidly absorbed when it is given in the form of rectal suppositories or intramuscular injection. Diclofenac is also absorbed percutaneously. Approximately 99 % of the drug is bound with the plasma proteins. Diclofenac passes in the synovial fluid and in the breast milk. Its plasmatic half life is 1 – 2 hours. It is excreted in the form of glucuronides and sulphates, mainly through urine (65 %) and bile (35 %).

Durilac is used:

• in musculo-skeletal disorders such as rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis;
• in peri-articular disorders such as bursitis and tendinitis;
• in soft-tissue disorders such as sprains and strains;
• in painful conditions such as renal colic, acute gout, dysmenorrhoea;
• after some surgical procedures.

Film coated tablets - 25 mg

Film-coated tablets - 10 mg

Eye drops solution - 0.3 %

Solution for injection - (50%) 1 g/2 ml

Solution for injection - 20 mg / ml

Buskolamin contains as active substance hyoscine butylbromide. Hyoscine butylbromide is a quaternary ammonium salt. This drug, due to its anticholinergic action, possesses antispasmodic properties and it is used to relieve smooth muscle spasms.

Buskolamin 20 mg/ml solution for injection is indicated:

• in acute spasm (spasm of the gastrointestinal tract and renal/biliary colic);

during diagnostic procedures (radiography or endoscopy).

Solution for infusion - 5% (50 g/1000 ml)

Film coated tablets - 300 mg

Cream - 10 mg / 1 g

Cream - 1%

Solution for injection - 25 mg/2 ml

Tablets - 250 mg

Solution for injection - 75 mg / 3 ml

Durilac contains the active substance diclofenac sodium, which is a non-steroidal anti-inflammatory drug (NSAID). Its action is based in the inhibition of cyclooxygenases, which participate in the biosynthesis of prostaglandins. Prostaglandins have an important role in the process of pain, inflammation and chills. Non - steroidal anti-inflammatory drugs inhibit cyclooxygenases-1 and-2 (COX-1 and-2). Inhibition of COX-1 is associated with gastrointestinal side effects, while the inhibition of COX-2 is associated with anti-inflammatory action.

Diclofenac is rapidly absorbed when it is given in the form of rectal suppositories or intramuscular injection. Diclofenac is also absorbed percutaneously. Approximately 99 % of the drug is bound with the plasma proteins. Diclofenac passes in the synovial fluid and in the breast milk. Its plasmatic half life is 1 – 2 hours. It is excreted in the form of glucuronides and sulphates, mainly through urine (65 %) and bile (35 %).

Durilac is used:

• in musculo-skeletal disorders such as rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis;
• in peri-articular disorders such as bursitis and tendinitis;
• in soft-tissue disorders such as sprains and strains;
• in painful conditions such as renal colic, acute gout, dysmenorrhoea;
• after some surgical procedures.